IVIG continues to be in short supply.  Supply is less than the demand, in part to the growing number of primary immune deficiency disease; off-label treatment uses, and increased geriatric population that is disposed to antibody deficiency disorders.  Usage is estimated to grow around 7% or more through 2022.

Some conservation suggestions:

  • Conservation
    • Reduce/Avoid waste
    • Prepare when patient arrives
    • Batch if have more than one patient
    • Round to the nearest vial size staying within 10% of the prescribed dose.
  • Work with provider to ensure appropriate use
    • Set up parameters via P&T/Medical Staff Committee

Contact PHV with questions or for further assistance.

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!